Nektar Therapeutics
(NKTR)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -118,961 | -276,056 | -368,198 | -523,837 | -444,440 |
| Depreciation Amortization | 4,391 | 84,316 | 13,030 | 14,146 | 14,182 |
| Income taxes - deferred | N/A | N/A | 2,708 | -102 | -36 |
| Accounts receivable | -3,045 | 4,776 | 16,511 | 12,397 | 1,913 |
| Accounts payable and accrued liabilities | 2,668 | -2,884 | 3,103 | -11,690 | 2,382 |
| Other Working Capital | -6,239 | -19,940 | 492 | -22,974 | 16,748 |
| Other Operating Activity | -54,523 | 17,182 | 28,347 | 119,400 | 95,964 |
| Operating Cash Flow | $-175,709 | $-192,606 | $-304,007 | $-412,660 | $-313,287 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -1,468 | 380 | 7,520 | -14,989 | -7,258 |
| Net Acquisitions | 65,386 | N/A | N/A | N/A | N/A |
| Purchase Of Investment | -261,709 | -511,699 | -467,914 | -960,689 | -987,533 |
| Sale Of Investment | 340,361 | 650,883 | 826,229 | 1,178,455 | 1,491,004 |
| Investing Cash Flow | $142,570 | $139,564 | $365,835 | $202,777 | $496,213 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | N/A | N/A | N/A | N/A | -250,000 |
| Common Stock Issued | 30,118 | 30 | 758 | 33,238 | 23,396 |
| Common Stock Repurchased | -3,000 | N/A | N/A | N/A | N/A |
| Other Financing Activity | 15,000 | 0 | 750 | 3,000 | 146,250 |
| Financing Cash Flow | $42,118 | $30 | $1,508 | $36,238 | $-80,354 |
| Exchange Rate Effect | -4 | 62 | -327 | -92 | 20 |
| Beginning Cash Position | 35,277 | 88,227 | 25,218 | 198,955 | 96,363 |
| End Cash Position | 44,252 | 35,277 | 88,227 | 25,218 | 198,955 |
| Net Cash Flow | $8,975 | $-52,950 | $63,009 | $-173,737 | $102,592 |
| Free Cash Flow | |||||
| Operating Cash Flow | -175,709 | -192,606 | -304,007 | -412,660 | -313,287 |
| Capital Expenditure | -1,468 | -865 | -5,676 | -14,989 | -7,258 |
| Free Cash Flow | -177,177 | -193,471 | -309,683 | -427,649 | -320,545 |